Business Wire

DroneBase Secures $55 Million and Launches Next Stage of Advanced Inspection Under New Brand Zeitview

7.2.2023 14:00:00 EET | Business Wire | Press release

Share

Further cementing its market leadership in advanced inspection software for energy and infrastructure, DroneBase has secured $55 million in investment and rebranded as Zeitview. Led by Valor Equity Partners, an operational growth investment firm backing technology and technology-enabled companies, the round was followed by existing investors Union Square Ventures, Upfront Ventures, Euclidean Capital, Energy Transition Ventures, and Hearst Ventures. The new funding will support the company’s AI-enabled software and global footprint in advanced inspection solutions. This announcement caps a year of rapid growth within the renewable sector, including the launch of the North American Solar Scan (NASS), the first standardized set of solar asset ratings to ensure better oversight of U.S. solar power plants. Last year, Zeitview inspected 43 GW of solar capacity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230207005174/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Zeitview inspection professionals use crewed aircraft and smartphone technologies to create relevant, flexible solutions for clients. Its accompanying software platform with deep insights and analytics allows clients to easily view data results anywhere. (Graphic: Business Wire)

As Zeitview, the company will continue building advanced inspection software that delivers fast, accurate insights, lowers costs for asset owners and improves performance and longevity. The name change comes with the company’s increasingly diverse data capture tools: alongside rotary wing drones, Zeitview inspection professionals use crewed aircraft and smartphone technologies to create relevant, flexible solutions for clients. Its accompanying software platform with deep insights and analytics allows clients to easily view data results anywhere.

“We appreciate how important time is to our customers: on the one hand, they need immediate and accurate analysis about the health of their assets; on the other, they are building energy and infrastructure resources to last for decades,” said Dan Burton, founder and chief executive officer at Zeitview. “We are confident that our AI-enabled software solutions can deliver that immediate answer and a long-term home for our customers, while we are increasingly agnostic about what tool we use to capture the most accurate data. We are grateful that Valor recognizes the power of our comprehensive services to support customers to build, protect, and maintain infrastructure across multiple asset classes and around the world. They understand transformational energy and infrastructure software and embrace businesses that use technology to solve operationally complex problems.”

Valor’s partnership enables Zeitview to continue transforming the aerial inspection industry with emerging technologies and exclusive AI software. Valor’s hands-on operational track record with complex software-led companies bolsters Zeitview’s commitment to increasing data capture capabilities through automation.

“Valor has been a long-term champion of data science and analytics to improve businesses,” said Vivek Pattipati, Partner at Valor Equity Partners. “With Zeitview’s continued expansion of services and commitment to delivering accurate, real-time insights through advanced inspection software, we are naturally mission-aligned. We look forward to supporting Zeitview as they launch this rebrand and enter the next phase of aerial imagery and data solutions.”

Zeitview means “time view” and better captures the nature of the company’s services and mission to accelerate the transition to renewable energy and sustainable infrastructure. In addition to providing real-time data, Zeitview offers long-term solutions to track changes across a period of time for an asset. Zeitview remains committed to building on the foundation of market leadership in drone services while engaging new tools for the evolving needs of the customer base. With last year’s launch of the NASS, the ability to serve as a one-stop shop for asset owners across multiple markets, and a continually expanding network of pilots around the globe, Zeitview is trailblazing the future of information gathering without limits.

For more information on how Zeitview makes aerial inspection data accessible across markets, please visit www.zeitview.com.

About Zeitview

For global customers in energy and infrastructure, Zeitview builds advanced inspection software that delivers fast, accurate insights, lowers costs, and improves asset performance and longevity. We are second to none at partnering with our customers to achieve flexible, long-term solutions across their multiple asset classes. Trusted by the largest enterprises in the world, Zeitview is active in over 70 countries. Learn more at www.zeitview.com.

About Valor Equity Partners

Valor Equity Partners is an operational growth investment firm focused on investing in high-growth companies across various stages of development. For decades, Valor has served its companies with unique expertise to solve the challenges of growth and scale. Valor partners with leading companies and entrepreneurs who are committed to the highest standards of excellence and the courage to transform their industries. For more information on Valor Equity Partners, please visit www.valorep.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Technica Communications
Cait Caviness
zeitview@technica.inc

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye